“Bringing these three companies together allows us to deliver an integrated and continuous experience for both providers and patients to yield healthier lifestyles and habits that lead to better outcomes, lower system cost and higher patient satisfaction, leading to value-based care.”
FORT LAUDERDALE, Fla. (PRWEB) November 12, 2020
ChronWell, a digital health and technology-enabled remote care management company, today announced its strategic partnership with ModifyHealth, a nationwide provider of gut-friendly, fully prepared meals, and Echosens North America, a high-technology company offering the FibroScan family of products. This collaboration will create LIVErHEALTHY, a newly integrated program that provides better outcomes and best-in-class service for Medicare patients managing chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Providing a holistic, tailored and technology-enabled approach to managing chronic liver diseases, LIVErHEALTHY links ChronWell’s Chronic Care Management (CCM) Program with ModifyHealth’s intuitive food and diet regime, and Echosen’s frequent non-invasive liver testing.
LIVErHEALTHY will utilize the tools and services provided by ChronWell’s CCM Program. This will enable its experienced Care Navigators to extend services beyond the walls of a doctor’s office, working closely with providers as well as ModifyHealth and Echosens to remotely manage patients in-between visits. This is done through care coordination, real-time monitoring and routine check-ins, ensuring adherence to tailored care plans.
“Liver diseases require continuous care and helping drive patient behavior once they leave the medical office is the only way to get optimal results,” said Joe Rubinsztain, MD, CEO of ChronWell. “Bringing these three companies together allows us to deliver an integrated and continuous experience for both providers and patients to yield healthier lifestyles and habits that lead to better outcomes, lower system cost and higher patient satisfaction, leading to value-based care.”
According to the American Liver Foundation, the first line of treatment for NAFLD/NASH is weight loss, done through a combination of calorie reduction, exercise and healthy eating. ModifyHealth makes medical nutrition therapy (MNT) simple and effective for healthcare providers and helps form the backbone of any treatment strategy or care plan. With the goal of bringing relief and making dietary management easier, ModifyHealth and its dieticians create catered regimens and send chef-inspired meals that are fully prepared, organic, gluten-free and follow a Low-FODMAP diet plan directly to the patient’s home.
"We're excited to partner with both ChronWell and Echosens to provide a streamlined solution for GI practices and their NAFLD/NASH patients," said Hagan Jordan, Chief Commercial Officer at ModifyHealth. "MNT plays a critical role in the management and treatment of these diseases, and our mission is to provide a resource for health care and providers that makes these necessary lifestyle changes easier and more effective."
In order to more effectively manage patients with chronic diseases, Echosens’ innovative tool, FibroScan, is used. FibroScan is an FDA-cleared, noninvasive and portable technology for the assessment of liver steatosis and fibrosis as an aid to the diagnosis and monitoring of liver health. FibroScan technology provides an effective platform for identification of patients with progressive fatty liver disease, including NAFLD/NASH. Additionally, longitudinal FibroScan testing can be used to monitor therapeutic response to care. FibroScan is used worldwide in over 6,500 clinics and validated in over 2,500 peer review publications.
“This strategic partnership is a powerful combination that reflects our collective commitment to ending the epidemic of fatty liver disease and halting the progression of NAFLD/NASH,” said Jon Gingrich, CEO of Echosens North America. “FibroScan complements the LIVErHEALTHY program and its treatment strategies, proving to be an important tool for improving individual patient outcomes. Working collaboratively with our partners, we can also sharpen our focus on cost-containment for all self-funded employers and payers. With shared dedication and alignment to value-based care, we look forward to supporting the marketplace as it prepares for the entry of specialty pharmaceuticals.”
To learn more about LIVErHEALTHY, click here.
ChronWell improves outcomes and reduces the cost of health care by offering a digital health platform with remote care coordination services for targeted populations. ChronWell is redefining how value-based care is delivered to patients by pairing highly skilled care teams with advanced digital technologies. ChronWell aims to improve patients’ lives beyond the walls of the physician’s office and minimize the impact of chronic conditions on patients, providers, employers and insurers. For more information, follow us on LinkedIn or visit chronwell.com.
ModifyHealth changes lives by making food as medicine simple and effective for providers and patients. ModifyHealth's provider-recommended, home-delivered, Low-FODMAP, and gluten-free meals are shipped nationwide to help bring relief to common GI conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), SIBO, and celiac disease where dietary modification is a recommended treatment. Meals are Monash University Low-FODMAP Certified, organic, non-GMO, delivered fully prepared and supported with expert dietitian consultations to ensure positive outcomes. For more information, please visit modifyhealth.com.
About Echosens North America
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans. For more information, please visit https://echosens.us/.